INBX Competitors & Alternatives
Compare Inhibrx Biosciences, Inc. with similar stocks in the same industry
Biotechnology
INBX
Main Stock$82.05
Tradestie Score
50
Market Cap
$492.21M
Revenue Growth
-1.0%
Analyst Upside
+238.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.08
|
$1.29B | 120.3 | 60 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$28.86
|
$1.29B | - | 59 | Compare |
|
ARDX
Ardelyx, Inc.
|
$4.95
|
$1.29B | - | 60 | Compare |
|
ZYME
Zymeworks Inc.
|
$21.94
|
$1.28B | - | 49 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.33
|
$1.27B | - | 59 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$47.13
|
$1.26B | - | 51 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.18
|
$1.22B | - | 55 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.27
|
$1.18B | - | 60 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$54.81
|
$1.17B | - | 52 | Compare |
More INBX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry